Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Total revenue is now expected to increase by a low-teens percentage while core EPS is slated to increase by a low double-digit to low-teens percentage
Bezin J, Gouverneur A, Pnichon M, et al
Food and Drug Administration (FDA) has yet to approve an oral GLP-1 therapy for chronic weight management
However, the massive use of GLP-1 agonists is under pharmacological surveillance, and evidence about long-term safety, efficacy and compliance is still being collected
US$ 21.34
US$ 26.83
US$ 20.74
